1 Human Immunoglobulin for Intravenous Injection Market Overview 1.1 Human Immunoglobulin for Intravenous Injection Product Overview 1.2 Human Immunoglobulin for Intravenous Injection Market Segment by Type 1.2.1 Children 1.2.2 Adult 1.3 Global Human Immunoglobulin for Intravenous Injection Market Size by Type 1.3.1 Global Human Immunoglobulin for Intravenous Injection Market Size Overview by Type (2016-2027) 1.3.2 Global Human Immunoglobulin for Intravenous Injection Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Human Immunoglobulin for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.2 Europe Human Immunoglobulin for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Human Immunoglobulin for Intravenous Injection Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Breakdown by Type (2016-2021) 2 Global Human Immunoglobulin for Intravenous Injection Market Competition by Company 2.1 Global Top Players by Human Immunoglobulin for Intravenous Injection Sales (2016-2021) 2.2 Global Top Players by Human Immunoglobulin for Intravenous Injection Revenue (2016-2021) 2.3 Global Top Players Human Immunoglobulin for Intravenous Injection Price (2016-2021) 2.4 Global Top Manufacturers Human Immunoglobulin for Intravenous Injection Manufacturing Base Distribution, Sales Area, Product Type 2.5 Human Immunoglobulin for Intravenous Injection Market Competitive Situation and Trends 2.5.1 Human Immunoglobulin for Intravenous Injection Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Human Immunoglobulin for Intravenous Injection Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immunoglobulin for Intravenous Injection as of 2020) 2.7 Date of Key Manufacturers Enter into Human Immunoglobulin for Intravenous Injection Market 2.8 Key Manufacturers Human Immunoglobulin for Intravenous Injection Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Human Immunoglobulin for Intravenous Injection Status and Outlook by Region 3.1 Global Human Immunoglobulin for Intravenous Injection Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Human Immunoglobulin for Intravenous Injection Historic Market Size by Region 3.2.1 Global Human Immunoglobulin for Intravenous Injection Sales in Volume by Region (2016-2021) 3.2.2 Global Human Immunoglobulin for Intravenous Injection Sales in Value by Region (2016-2021) 3.2.3 Global Human Immunoglobulin for Intravenous Injection Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Region 3.3.1 Global Human Immunoglobulin for Intravenous Injection Sales in Volume by Region (2022-2027) 3.3.2 Global Human Immunoglobulin for Intravenous Injection Sales in Value by Region (2022-2027) 3.3.3 Global Human Immunoglobulin for Intravenous Injection Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Human Immunoglobulin for Intravenous Injection by Application 4.1 Human Immunoglobulin for Intravenous Injection Market Segment by Application 4.1.1 Disease Prevention 4.1.2 Treatment 4.1.3 Diagnosis 4.1.4 Other 4.2 Global Human Immunoglobulin for Intravenous Injection Market Size by Application 4.2.1 Global Human Immunoglobulin for Intravenous Injection Market Size Overview by Application (2016-2027) 4.2.2 Global Human Immunoglobulin for Intravenous Injection Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Human Immunoglobulin for Intravenous Injection Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Human Immunoglobulin for Intravenous Injection Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Human Immunoglobulin for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.2 Europe Human Immunoglobulin for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Human Immunoglobulin for Intravenous Injection Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Breakdown by Application (2016-2021) 5 North America Human Immunoglobulin for Intravenous Injection by Country 5.1 North America Human Immunoglobulin for Intravenous Injection Historic Market Size by Country 5.1.1 North America Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2016-2021) 5.1.2 North America Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2016-2021) 5.2 North America Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Country 5.2.1 North America Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2022-2027) 5.2.2 North America Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2022-2027) 6 Europe Human Immunoglobulin for Intravenous Injection by Country 6.1 Europe Human Immunoglobulin for Intravenous Injection Historic Market Size by Country 6.1.1 Europe Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2016-2021) 6.1.2 Europe Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2016-2021) 6.2 Europe Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Country 6.2.1 Europe Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2022-2027) 6.2.2 Europe Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2022-2027) 7 Asia-Pacific Human Immunoglobulin for Intravenous Injection by Region 7.1 Asia-Pacific Human Immunoglobulin for Intravenous Injection Historic Market Size by Region 7.1.1 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Region 7.2.1 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales in Value by Region (2022-2027) 8 Latin America Human Immunoglobulin for Intravenous Injection by Country 8.1 Latin America Human Immunoglobulin for Intravenous Injection Historic Market Size by Country 8.1.1 Latin America Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2016-2021) 8.1.2 Latin America Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2016-2021) 8.2 Latin America Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Country 8.2.1 Latin America Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2022-2027) 8.2.2 Latin America Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2022-2027) 9 Middle East and Africa Human Immunoglobulin for Intravenous Injection by Country 9.1 Middle East and Africa Human Immunoglobulin for Intravenous Injection Historic Market Size by Country 9.1.1 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Human Immunoglobulin for Intravenous Injection Forecasted Market Size by Country 9.2.1 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Human Immunoglobulin for Intravenous Injection Business 10.1 Tiantan Biological 10.1.1 Tiantan Biological Corporation Information 10.1.2 Tiantan Biological Introduction and Business Overview 10.1.3 Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.1.5 Tiantan Biological Recent Development 10.2 Taibang Biological 10.2.1 Taibang Biological Corporation Information 10.2.2 Taibang Biological Introduction and Business Overview 10.2.3 Taibang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Tiantan Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.2.5 Taibang Biological Recent Development 10.3 Shanghai Laishi 10.3.1 Shanghai Laishi Corporation Information 10.3.2 Shanghai Laishi Introduction and Business Overview 10.3.3 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Shanghai Laishi Human Immunoglobulin for Intravenous Injection Products Offered 10.3.5 Shanghai Laishi Recent Development 10.4 Hualan Biological 10.4.1 Hualan Biological Corporation Information 10.4.2 Hualan Biological Introduction and Business Overview 10.4.3 Hualan Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Hualan Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.4.5 Hualan Biological Recent Development 10.5 Zhenghua Shenghua 10.5.1 Zhenghua Shenghua Corporation Information 10.5.2 Zhenghua Shenghua Introduction and Business Overview 10.5.3 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Products Offered 10.5.5 Zhenghua Shenghua Recent Development 10.6 Yuanda shuyang 10.6.1 Yuanda shuyang Corporation Information 10.6.2 Yuanda shuyang Introduction and Business Overview 10.6.3 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Yuanda shuyang Human Immunoglobulin for Intravenous Injection Products Offered 10.6.5 Yuanda shuyang Recent Development 10.7 Weiguang Biological 10.7.1 Weiguang Biological Corporation Information 10.7.2 Weiguang Biological Introduction and Business Overview 10.7.3 Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Weiguang Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.7.5 Weiguang Biological Recent Development 10.8 Boya Biological 10.8.1 Boya Biological Corporation Information 10.8.2 Boya Biological Introduction and Business Overview 10.8.3 Boya Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Boya Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.8.5 Boya Biological Recent Development 10.9 Nanyue Biological 10.9.1 Nanyue Biological Corporation Information 10.9.2 Nanyue Biological Introduction and Business Overview 10.9.3 Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Nanyue Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.9.5 Nanyue Biological Recent Development 10.10 Paisi feike 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Human Immunoglobulin for Intravenous Injection Product Category, Application and Specification 10.10.3 Paisi feike Human Immunoglobulin for Intravenous Injection Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Paisi feike Recent Development 10.11 Kangbao Biological 10.11.1 Kangbao Biological Corporation Information 10.11.2 Kangbao Biological Introduction and Business Overview 10.11.3 Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Kangbao Biological Human Immunoglobulin for Intravenous Injection Products Offered 10.11.5 Kangbao Biological Recent Development 10.12 Lvshizi 10.12.1 Lvshizi Corporation Information 10.12.2 Lvshizi Introduction and Business Overview 10.12.3 Lvshizi Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Lvshizi Human Immunoglobulin for Intravenous Injection Products Offered 10.12.5 Lvshizi Recent Development 10.13 Zhongyuan Ruide 10.13.1 Zhongyuan Ruide Corporation Information 10.13.2 Zhongyuan Ruide Introduction and Business Overview 10.13.3 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Products Offered 10.13.5 Zhongyuan Ruide Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Human Immunoglobulin for Intravenous Injection Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Human Immunoglobulin for Intravenous Injection Industrial Chain Analysis 11.4 Human Immunoglobulin for Intravenous Injection Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Human Immunoglobulin for Intravenous Injection Distributors 12.3 Human Immunoglobulin for Intravenous Injection Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Children Table 2. Major Company of Adult Table 3. Global Human Immunoglobulin for Intravenous Injection Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (K Units) Table 5. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type (2016-2021) Table 6. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US& Million) Table 7. Global Human Immunoglobulin for Intravenous Injection Market Share in Value by Type (2016-2021) Table 8. Global Human Immunoglobulin for Intravenous Injection Price by Type (2016-2021) & (US$/Unit) Table 9. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2022-2027) & (K Units) Table 10. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type (2022-2027) Table 11. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2022-2027) & (US$ Million) Table 12. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type (2022-2027) Table 13. Global Human Immunoglobulin for Intravenous Injection Price by Type (2022-2027) & (US$/Unit) Table 14. North America Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (K Units) Table 15. North America Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 17. Europe Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 19. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 21. Latin America Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales (K Units) by Type (2016-2021) Table 23. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2021) & (US$ Million) Table 24. Global Human Immunoglobulin for Intravenous Injection Sales by Company (2016-2021) & (K Units) Table 25. Global Human Immunoglobulin for Intravenous Injection Sales Share by Company (2016-2021) Table 26. Global Human Immunoglobulin for Intravenous Injection Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Human Immunoglobulin for Intravenous Injection Revenue Share by Company (2016-2021) Table 28. Global Market Human Immunoglobulin for Intravenous Injection Price by Company (2016-2021) & (US$/Unit) Table 29. Global Human Immunoglobulin for Intravenous Injection Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Human Immunoglobulin for Intravenous Injection Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Immunoglobulin for Intravenous Injection as of 2020 Table 32. Date of Key Manufacturers Enter into Human Immunoglobulin for Intravenous Injection Market Table 33. Key Manufacturers Human Immunoglobulin for Intravenous Injection Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Human Immunoglobulin for Intravenous Injection Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2016-2021) & (K Units) Table 37. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Region (2016-2021) Table 38. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2016-2021) & (US$ Million) Table 39. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Region (2016-2021) Table 40. Global Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 41. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2022-2027) & (K Units) Table 42. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Region (2022-2027) Table 43. Global Human Immunoglobulin for Intravenous Injection Sales by Region (2022-2027) & (US$ Million) Table 44. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Region (2022-2027) Table 45. Global Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027) Table 46. Global Human Immunoglobulin for Intravenous Injection Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (K Units) Table 48. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Application (2016-2021) Table 49. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 50. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application (2016-2021) Table 51. Global Human Immunoglobulin for Intravenous Injection Price by Application (2016-2021) & (US$/Unit) Table 52. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2022-2027) & (K Units) Table 53. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Application (2022-2027) Table 54. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2022-2027) & (US$ Million) Table 55. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application (2022-2027) Table 56. Global Human Immunoglobulin for Intravenous Injection Price by Application (2022-2027) & (US$/Unit) Table 57. North America Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 58. North America Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 59. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 60. Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 61. Europe Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 64. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 66. Latin America Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 67. Latin America Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) (K Units) Table 70. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Table 72. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 73. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 74. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 75. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 76. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 77. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 78. North America Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 79. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 80. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 81. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 84. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 85. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Region (2016-2021) & (K Units) Table 89. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Region (2022-2027) & (K Units) Table 93. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 97. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 101. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (K Units) Table 105. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (K Units) Table 109. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Country (2022-2027) Table 112. Tiantan Biological Corporation Information Table 113. Tiantan Biological Introduction and Business Overview Table 114. Tiantan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Tiantan Biological Human Immunoglobulin for Intravenous Injection Product Table 116. Tiantan Biological Recent Development Table 117. Taibang Biological Corporation Information Table 118. Taibang Biological Introduction and Business Overview Table 119. Taibang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Taibang Biological Human Immunoglobulin for Intravenous Injection Product Table 121. Taibang Biological Recent Development Table 122. Shanghai Laishi Corporation Information Table 123. Shanghai Laishi Introduction and Business Overview Table 124. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Shanghai Laishi Human Immunoglobulin for Intravenous Injection Product Table 126. Shanghai Laishi Recent Development Table 127. Hualan Biological Corporation Information Table 128. Hualan Biological Introduction and Business Overview Table 129. Hualan Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Hualan Biological Human Immunoglobulin for Intravenous Injection Product Table 131. Hualan Biological Recent Development Table 132. Zhenghua Shenghua Corporation Information Table 133. Zhenghua Shenghua Introduction and Business Overview Table 134. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Zhenghua Shenghua Human Immunoglobulin for Intravenous Injection Product Table 136. Zhenghua Shenghua Recent Development Table 137. Yuanda shuyang Corporation Information Table 138. Yuanda shuyang Introduction and Business Overview Table 139. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. Yuanda shuyang Human Immunoglobulin for Intravenous Injection Product Table 141. Yuanda shuyang Recent Development Table 142. Weiguang Biological Corporation Information Table 143. Weiguang Biological Introduction and Business Overview Table 144. Weiguang Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. Weiguang Biological Human Immunoglobulin for Intravenous Injection Product Table 146. Weiguang Biological Recent Development Table 147. Boya Biological Corporation Information Table 148. Boya Biological Introduction and Business Overview Table 149. Boya Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Boya Biological Human Immunoglobulin for Intravenous Injection Product Table 151. Boya Biological Recent Development Table 152. Nanyue Biological Corporation Information Table 153. Nanyue Biological Introduction and Business Overview Table 154. Nanyue Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. Nanyue Biological Human Immunoglobulin for Intravenous Injection Product Table 156. Nanyue Biological Recent Development Table 157. Paisi feike Corporation Information Table 158. Paisi feike Introduction and Business Overview Table 159. Paisi feike Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Paisi feike Human Immunoglobulin for Intravenous Injection Product Table 161. Paisi feike Recent Development Table 162. Kangbao Biological Corporation Information Table 163. Kangbao Biological Introduction and Business Overview Table 164. Kangbao Biological Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. Kangbao Biological Human Immunoglobulin for Intravenous Injection Product Table 166. Kangbao Biological Recent Development Table 167. Lvshizi Corporation Information Table 168. Lvshizi Introduction and Business Overview Table 169. Lvshizi Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 170. Lvshizi Human Immunoglobulin for Intravenous Injection Product Table 171. Lvshizi Recent Development Table 172. Zhongyuan Ruide Corporation Information Table 173. Zhongyuan Ruide Introduction and Business Overview Table 174. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 175. Zhongyuan Ruide Human Immunoglobulin for Intravenous Injection Product Table 176. Zhongyuan Ruide Recent Development Table 177. Key Raw Materials Lists Table 178. Raw Materials Key Suppliers Lists Table 179. Human Immunoglobulin for Intravenous Injection Market Trends Table 180. Human Immunoglobulin for Intravenous Injection Market Drivers Table 181. Human Immunoglobulin for Intravenous Injection Market Challenges Table 182. Human Immunoglobulin for Intravenous Injection Market Restraints Table 183. Human Immunoglobulin for Intravenous Injection Distributors List Table 184. Human Immunoglobulin for Intravenous Injection Downstream Customers Table 185. Research Programs/Design for This Report Table 186. Key Data Information from Secondary Sources Table 187. Key Data Information from Primary Sources List of Figures Figure 1. Human Immunoglobulin for Intravenous Injection Product Picture Figure 2. Global Human Immunoglobulin for Intravenous Injection Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Human Immunoglobulin for Intravenous Injection Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Human Immunoglobulin for Intravenous Injection Sales Status and Outlook (2016-2027) & (K Units) Figure 5. Product Picture of Children Figure 6. Global Children Sales YoY Growth (2016-2021) & (K Units) Figure 7. Product Picture of Adult Figure 8. Global Adult Sales YoY Growth (2016-2021) & (K Units) Figure 9. Global Human Immunoglobulin for Intravenous Injection Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type (2016-2021) Figure 12. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type (2022-2027) Figure 14. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 15. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 16. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 17. Europe Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 20. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Immunoglobulin for Intravenous Injection Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Immunoglobulin for Intravenous Injection Revenue in 2020 Figure 26. Human Immunoglobulin for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of Disease Prevention Figure 28. Global Disease Prevention Sales YoY Growth (2016-2027) & (K Units) Figure 29. Product Picture of Treatment Figure 30. Global Treatment Sales YoY Growth (2016-2027) & (K Units) Figure 31. Product Picture of Diagnosis Figure 32. Global Diagnosis Sales YoY Growth (2016-2027) & (K Units) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Units) Figure 35. Global Human Immunoglobulin for Intravenous Injection Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application (2016-2021) Figure 38. Global Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Human Immunoglobulin for Intravenous Injection Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Human Immunoglobulin for Intravenous Injection Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Human Immunoglobulin for Intravenous Injection Manufacturing Cost Structure Figure 44. Human Immunoglobulin for Intravenous Injection Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Tiantan Biological Taibang Biological Shanghai Laishi Hualan Biological Zhenghua Shenghua Yuanda shuyang Weiguang Biological Boya Biological Nanyue Biological Paisi feike Kangbao Biological Lvshizi Zhongyuan Ruide